These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 476980)

  • 21. [Therapy of Addison's disease].
    Tiede N; Hofbauer LC; Bornstein SR; Kirch W
    Dtsch Med Wochenschr; 2010 Aug; 135(31-32):1561-2. PubMed ID: 20665422
    [No Abstract]   [Full Text] [Related]  

  • 22. Steroid replacement in Addison's disease and in subjects adrenalectomized for Cushing's disease: comparison of various glucocorticoids.
    Khalid BA; Burke CW; Hurley DM; Funder JW; Stockigt JR
    J Clin Endocrinol Metab; 1982 Sep; 55(3):551-9. PubMed ID: 6284785
    [No Abstract]   [Full Text] [Related]  

  • 23. Takotsubo-like syndrome triggered by fludrocortisone overdose for Addison's disease: a case report.
    Campean R; Hasun M; Stöllberger C; Bucher J; Finsterer J; Schnack C; Weidinger F
    J Med Case Rep; 2016 Oct; 10(1):281. PubMed ID: 27729057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypothyroidism and Addison's disease totally corrected by adrenal replacement therapy.
    Schwartz WL
    Calif Med; 1973 Feb; 118(2):57-60. PubMed ID: 4701710
    [No Abstract]   [Full Text] [Related]  

  • 25. Subjective health status in Norwegian patients with Addison's disease.
    Løvås K; Loge JH; Husebye ES
    Clin Endocrinol (Oxf); 2002 May; 56(5):581-8. PubMed ID: 12030907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
    Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of hypertension and heart failure in patients with Addison's disease.
    Inder WJ; Meyer C; Hunt PJ
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):789-92. PubMed ID: 25138826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
    Smans L; Lentjes E; Hermus A; Zelissen P
    Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A possible ACTH secreting tumour of the pituitary developing in a conventionally treated case of Addison's disease.
    Himsworth RL; Lewis JG; Rees LH
    Clin Endocrinol (Oxf); 1978 Aug; 9(2):131-9. PubMed ID: 212238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacological action of 9alpha-fluorohydrocortisone as a mineralocorticoid].
    Sekihara H
    Nihon Rinsho; 1994 Mar; 52(3):583-6. PubMed ID: 8164353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of potassium loading on sodium excretion and plasma renin activity in Addisonian man.
    Miller PD; Waterhouse C; Owens R; Cohen E
    J Clin Invest; 1975 Aug; 56(2):346-53. PubMed ID: 1150875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease.
    Løvås K; Thorsen TE; Husebye ES
    J Endocrinol Invest; 2006 Sep; 29(8):727-31. PubMed ID: 17033262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addison's disease.
    Nieman LK; Chanco Turner ML
    Clin Dermatol; 2006; 24(4):276-80. PubMed ID: 16828409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of plasma cortisol and ACTH concentrations in patients with Addison's disease treated with conventional corticosteroid replacement.
    Feek CM; Ratcliffe JG; Seth J; Gray CE; Toft AD; Irvine WJ
    Clin Endocrinol (Oxf); 1981 May; 14(5):451-8. PubMed ID: 6273020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating levels of adrenomedullin in patients with Addison's disease before and after corticosteroid treatment.
    Letizia C; Cerci S; Centanni M; De Toma G; Subioli S; Scuro L; Scavo D
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):145-8. PubMed ID: 9579224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replacement therapy for Addison's disease: recent developments.
    Løvås K; Husebye ES
    Expert Opin Investig Drugs; 2008 Apr; 17(4):497-509. PubMed ID: 18363515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in cortisol metabolism following rifampicin therapy.
    Edwards OM; Courtenay-Evans RJ; Galley JM; Hunter J; Tait AD
    Lancet; 1974 Sep; 2(7880):548-51. PubMed ID: 4140269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addison's disease, psychosis, and the syndrome of inappropriate secretion of antidiuretic hormone.
    Lever EG; Stansfeld SA
    Br J Psychiatry; 1983 Oct; 143():406-10. PubMed ID: 6414566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Irony I; Cutler GB
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Proceedings: Plasma renin activity in management of Addison's disease (author's transl)].
    Linquette M; Lefebvre J; Fossati P; Fourlinnie JC; Cappoen JP; Lecieux P
    Ann Endocrinol (Paris); 1975; 36(2):103-4. PubMed ID: 1190719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.